Search

everythinglearnresearchcommunity

for

Search:↓

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

AGD1's PH domain is essential for its role in root hair growth and polarity.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

AH-001 could be a safer and more effective treatment for hair loss.

PGD2 stops hair growth and is higher in bald men with AGA.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Gene linked to common hair loss found, may lead to new treatments.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Genetic marker rs12558842 strongly linked to male hair loss.

GALT5 and GALT2 are important for plant growth and development because they help with protein glycosylation.

Certain gene variations may increase the risk of hair loss in Egyptians.

A new treatment for hair loss shows promise with fewer side effects.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

EDA2R gene linked to hair loss.

Certain proteins are essential for the growth of root hairs in barley.

A new mouse mutation causes skin and hair defects due to a gene change.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

The Gsdma3 gene is essential for normal hair development in mice.